F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer.
- Conditions
- Patients treated for non-metastasized prostate cancer with a biochemical recurrence of prostate cancerTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2018-001267-22-NL
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 50
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Males = 18 years
- Histologically proven adenocarcinoma of the prostate
- Prior local treatment with curative intent
- Biochemical recurrence with PSA-levels of 0.2-5.0 ug/L
- PSA level determined <8 weeks before study participation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 35
A patient will be excluded from participation in the trial if one or more of the following criteria are met:
- Contra-indications for PET-CT: claustrophobia or inability to lay still for the duration of the exam.
- Other cancer < 2 years prior to biochemical recurrence
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method